|
Volumn 10, Issue 3, 2004, Pages 221-223
|
Prospects for an AIDS vaccine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
GLYCOPROTEIN GP 120;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CLINICAL TRIAL;
DRUG EFFICACY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RESPONSE;
MONKEY;
NONHUMAN;
PRIORITY JOURNAL;
REVIEW;
SUPERINFECTION;
TREATMENT FAILURE;
VACCINE PRODUCTION;
ANIMAL;
ARTICLE;
GENETICS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
IMMUNE SYSTEM;
IMMUNOLOGY;
METABOLISM;
PHYSIOLOGY;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
RNA VIRUSES;
AIDS VACCINES;
ANIMALS;
CLINICAL TRIALS;
HIV INFECTIONS;
HIV-1;
HUMANS;
IMMUNE SYSTEM;
|
EID: 2342463654
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/nm0304-221 Document Type: Review |
Times cited : (110)
|
References (19)
|